HONG KONG--(Marketwire - May 24, 2012) - Today, www.BrightonMarkets.com announced new reports highlighting Priceline.com Inc (NASDAQ: PCLN) and Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN). Gain market insight with full analysis and research downloads available at www.BrightonMarkets.com/index.php?coa=PCLN&cob=ALXN.
Economic fundamentals leading into 2012 have set a generally positive pace with GDP growth likely to pick up through the coming year. However, there are several important caveats to note as the world economy continues to face headwinds and risks weigh to the downside. Positive outlooks are conditional on fiscal policy in payroll taxes and unemployment insurance benefits and upon the easing of the European debt situation. A repeat of volatility experience in 2011 is likely in 2012, as perceptions about the strength of the U.S. economy and the euro zone will vary over time as events unfold.
Despite the current situation, our team continues to identify high momentum situations with growth potential -- there remains strong opportunity within careful discretion.
Brighton Markets is releasing new coverage on Priceline.com Inc for its current position within the services industry. priceline.com Incorporated is an online travel company that offers its customers hotel room reservations at over 210,000 hotels worldwide through the Booking.com, priceline.com and Agoda brands. In the United States, the Company also offers its customers reservations for car rentals, airline tickets, vacation packages, destination services and cruises through the priceline. The full research report on Priceline.com Inc (NASDAQ: PCLN) is available here: www.BrightonMarkets.com/index.php?coa=PCLN.
Brighton Markets has released research on Alexion Pharmaceuticals, Inc. for its changing role within the healthcare industry. Alexion Pharmaceuticals, Inc. (Alexion) is a biopharmaceutical company focused on serving patients with severe and ultra-rare disorders through the development and commercialization of life-transforming therapeutic products. The full research report on Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) is available here: www.BrightonMarkets.com/index.php?cob=ALXN.
About Brighton Markets
Brighton Markets was founded on the guiding principle of providing highly relevant, meaningful, and actionable information direct to investors. Across the investment spectrum, Brighton Markets shines light on today's events.